Company / Income Tax
Vanda Pharmaceuticals Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$3.8M
FY2025
5-year range
-$86.5M / $9.2M
FY2021-FY2025
Trend
-23.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax has fluctuated over the past 10 years, ranging from -$87M in FY2021 to $9M in FY2023.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +94.4%.
Improved from $9M to $4M over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -22.8%
- 5-Year CAGR
- +94.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +94.4%, indicating consistent growth.
- In FY2025, income tax decreased 23.8% year-over-year.
- Peak income tax was recorded in FY2023.
- Lowest income tax in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.8M | -23.8% |
| FY2024 | $5.0M | -45.5% |
| FY2023 | $9.2M | +10.7% |
| FY2022 | $8.3M | +109.6% |
| FY2021 | -$86.5M | -62799.3% |
| FY2020 | $138.0K | +1.5% |
| FY2019 | $136.0K | +30.8% |
| FY2018 | $104.0K | +0.0% |
| FY2017 | $104.0K | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026